HGF regulates the activation of TGF-β1 in rat hepatocytes and hepatic stellate cells

Journal of Cellular Physiology

Volumn 228, Issue 2, 2013, Pages 393-401

  Narmada, Balakrishnan Chakrapani ^a,b,c,d   Chia, Ser Mien ^b,e   Tucker Kellogg, Lisa ^c,e   Yu, Hanry ^{a,b,c,d,e,f,g}  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d INSTITUTE OF BIOENGINEERING AND NANOTECHNOLOGY   (Singapore)

^e SINGAPORE MIT ALLIANCE   (Singapore)

^f SINGAPORE MIT ALLIANCE FOR RESEARCH AND TECHNOLOGY   (Singapore)

^g Massachusetts Institute of Technology Cambridge   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; COLLAGEN TYPE 1; PLASMIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; SCATTER FACTOR; THROMBOSPONDIN 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; COCULTURE; CONTROLLED STUDY; GENE EXPRESSION; IN VITRO STUDY; LIVER CELL; LIVER CELL CULTURE; LIVER FIBROSIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; RAT; SIGNAL TRANSDUCTION; STELLATE CELL;

ANIMALS; APROTININ; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; COLLAGEN TYPE I; FIBRINOLYSIN; HEPATIC STELLATE CELLS; HEPATOCYTE GROWTH FACTOR; HEPATOCYTES; LIVER CIRRHOSIS; MALE; PEPTIDES; RATS; RATS, WISTAR; SERINE PROTEINASE INHIBITORS; SIGNAL TRANSDUCTION; THROMBOSPONDIN 1; TRANSFORMING GROWTH FACTOR BETA1;

RATTUS;

EID: 84868020504     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24143     Document Type: Article

References (50)

1. Abu-Absi SF, Hansen LK, Hu WS. 2004. Three-dimensional co-culture of hepatocytes and stellate cells. Cytotechnology 45:125-140.
2. Anonick PK, Yoo JK, Webb DJ, Gonias SL. 1993. Characterization of the antiplasmin activity of human thrombospondin-1 in solution. Biochem J 289:903-909.
3. Bataller R, Brenner DA. 2005. Liver fibrosis. J Clin Invest 115:209-218.
4. Bezerra JA, Bugge TH, Melin-Aldana H, Sabla G, Kombrinck KW, Witte DP, Degen JL. 1999. Plasminogen deficiency leads to impaired remodeling after a toxic injury to the liver. Proc Natl Acad Sci USA 96:15143-15148.
5. Bhandari RN, Riccalton LA, Lewis AL, Fry JR, Hammond AH, Tendler SJ, Shakesheff KM. 2001. Liver tissue engineering: A role for co-culture systems in modifying hepatocyte function and viability. Tissue Eng 7:345-357.
6. Blouin A, Bolender RP, Weibel ER. 1977. Distribution of organelles and membranes between hepatocytes and nonhepatocytes in the rat liver parenchyma. A stereological study. J Cell Biol 72:441-455.
7. Bonnefoy A, Legrand C. 2000. Proteolysis of subendothelial adhesive glycoproteins (fibronectin, thrombospondin, and von Willebrand factor) by plasmin, leukocyte cathepsin G, and elastase. Thromb Res 98:323-332.
8. Border WA, Noble NA. 1994. Transforming growth factor beta in tissue fibrosis. N Engl J Med 331:1286-1292.
9. Breitkopf K, Sawitza I, Westhoff JH, Wickert L, Dooley S, Gressner AM. 2005. Thrombospondin 1 acts as a strong promoter of transforming growth factor beta effects via two distinct mechanisms in hepatic stellate cells. Gut 54:673-681.
10. Budinger GR, Mutlu GM, Eisenbart J, Fuller AC, Bellmeyer AA, Baker CM, Wilson M, Ridge K, Barrett TA, Lee VY, Chandel NS. 2006. Proapoptotic Bid is required for pulmonary fibrosis. Proc Natl Acad Sci USA 103:4604-4609.
11. Bueno M, Salgado S, Beas-Zarate C, Armendariz-Borunda J. 2006. Urokinase-type plasminogen activator gene therapy in liver cirrhosis is mediated by collagens gene expression down-regulation and up-regulation of MMPs, HGF and VEGF. J Gene Med 8:1291-1299.
12. Dooley S, Delvoux B, Lahme B, Mangasser-Stephan K, Gressner AM. 2000. Modulation of transforming growth factor beta response and signaling during transdifferentiation of rat hepatic stellate cells to myofibroblasts. Hepatology 31:1094-1106.
13. Florquin S, Rouschop KM. 2003. Reciprocal functions of hepatocyte growth factor and transforming growth factor-beta 1 in the progression of renal diseases: A role for CD44? Kidney Int S15-S20.
14. Franklin TJ. 1997. Therapeutic approaches to organ fibrosis. Int J Biochem Cell Biol 29:79-89.
15. Ghosh AK, Vaughan DE. 2012. PAI-1 in tissue fibrosis. J Cell Physiol 227:493-507.
16. Guyot C, Lepreux S, Combe C, Doudnikoff E, Bioulac-Sage P, Balabaud C, Desmouliere A. 2006. Hepatic fibrosis and cirrhosis: The (myo)fibroblastic cell subpopulations involved. Int J Biochem Cell Biol 38:135-151.
17. Hayashi H, Sakai K, Baba H, Sakai T. 2012. Thrombospondin-1 is a novel negative regulator of liver regeneration after partial hepatectomy through transforming growth factor-beta 1 activation in mice. Hepatology 55:1562-1573.
18. Hogg PJ, Stenflo J, Mosher DF. 1992. Thrombospondin is a slow tight-binding inhibitor of plasmin. Biochemistry 31:265-269.
19. Horiguchi K, Hirano T, Ueki T, Hirakawa K, Fujimoto J. 2009. Treating liver cirrhosis in dogs with hepatocyte growth factor gene therapy via the hepatic artery. J Hepatobiliary Pancreat Surg 16:171-177.
20. Hu PF, Chen H, Zhong W, Lin Y, Zhang X, Chen YX, Xie WF. 2009. Adenovirus-mediated transfer of siRNA against PAI-1 mRNA ameliorates hepatic fibrosis in rats. J Hepatol 51:102-113.
21. Hughes RD, Mitry RR, Dhawan A. 2012. Current status of hepatocyte transplantation. Transplantation 93:342-347, 310.1097/TP.1090b1013e31823b31872d31826.
22. Inoue T, Okada H, Kobayashi T, Watanabe Y, Kanno Y, Kopp JB, Nishida T, Takigawa M, Ueno M, Nakamura T, Suzuki H. 2003. Hepatocyte growth factor counteracts transforming growth factor-beta 1, through attenuation of connective tissue growth factor induction, and prevents renal fibrogenesis in 5/6 nephrectomized mice. FASEB J 17:268-270.
23. Inoue H, Yokoyama F, Kita Y, Yoshiji H, Tsujimoto T, Deguchi A, Nakai S, Morishita A, Uchida N, Masaki T, Watanabe S, Kuriyama S. 2006. Relationship between the proliferative capability of hepatocytes and the intrahepatic expression of hepatocyte growth factor and c-Met in the course of cirrhosis development in rats. Int J Mol Med 17:857-864.
24. Iredale JP. 2001. Hepatic stellate cell behavior during resolution of liver injury. Semin Liver Dis 21:427-436.
25. Jiang D, Jiang Z, Han F, Zhang Y, Li Z. 2008. HGF suppresses the production of collagen type III and alpha-SMA induced by TGF-beta 1 in healing fibroblasts. Eur J Appl Physiol 103:489-493.
26. Kim WH, Matsumoto K, Bessho K, Nakamura T. 2005. Growth inhibition and apoptosis in liver myofibroblasts promoted by hepatocyte growth factor leads to resolution from liver cirrhosis. Am J Pathol 166:1017-1028.
27. Kisseleva T, Brenner DA. 2007. Role of hepatic stellate cells in fibrogenesis and the reversal of fibrosis. J Gastroenterol Hepatol 22:S73-S78.
28. Kondou H, Mushiake S, Etani Y, Miyoshi Y, Michigami T, Ozono K. 2003. A blocking peptide for transforming growth factor-beta1 activation prevents hepatic fibrosis in vivo. J Hepatol 39:742-748.
29. Li F, Sun JY, Wang JY, Du SL, Lu WY, Liu M, Xie C, Shi JY. 2008. Effect of hepatocyte growth factor encapsulated in targeted liposomes on liver cirrhosis. J Control Release 131:77-82.
30. Longstaff C. 1994. Studies on the mechanisms of action of aprotinin and tranexamic acid as plasmin inhibitors and antifibrinolytic agents. Blood Coagul Fibrinolysis 5:537-542.
31. Martinez-Rizo A, Bueno-Topete M, Gonzalez-Cuevas J, Armendariz-Borunda J. 2010. Plasmin plays a key role in the regulation of profibrogenic molecules in hepatic stellate cells. Liver Int 30:298-310.
32. Munger JS, Harpel JG, Gleizes PE, Mazzieri R, Nunes I, Rifkin DB. 1997. Latent transforming growth factor-beta: Structural features and mechanisms of activation. Kidney Int 51:1376-1382.
33. Murphy-Ullrich JE, Schultz-Cherry S, Hook M. 1992. Transforming growth factor-beta complexes with thrombospondin. Mol Biol Cell 3:181-188.
34. Nishimura K, Matsumiya K, Miura H, Tsujimura A, Nonomura N, Matsumoto K, Nakamura T, Okuyama A. 2003. Effects of hepatocyte growth factor on urokinase-type plasminogen activator (uPA) and uPA receptor in DU145 prostate cancer cells. Int J Androl 26:175-179.
35. Nishino M, Iimuro Y, Ueki T, Hirano T, Fujimoto J. 2008. Hepatocyte growth factor improves survival after partial hepatectomy in cirrhotic rats suppressing apoptosis of hepatocytes. Surgery 144:374-384.
36. Ochiya T, Yamamoto Y, Banas A. 2010. Commitment of stem cells into functional hepatocytes. Differentiation 79:65-73.
37. Pedrozo HA, Schwartz Z, Robinson M, Gomes R, Dean DD, Bonewald LF, Boyan BD. 1999. Potential mechanisms for the plasmin-mediated release and activation of latent transforming growth factor-beta 1 from the extracellular matrix of growth plate chondrocytes. Endocrinology 140:5806-5816.
38. Sato Y, Rifkin DB. 1989. Inhibition of endothelial cell movement by pericytes and smooth muscle cells: Activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture. J Cell Biol 109:309-315.
39. Scarpino S, Di Napoli A, Taraboletti G, Cancrini A, Ruco LP. 2005. Hepatocyte growth factor (HGF) downregulates thrombospondin 1 (TSP-1) expression in thyroid papillary carcinoma cells. J Pathol 205:50-56.
40. Seglen PO. 1976. Preparation of isolated rat liver cells. Methods Cell Biol 13:29-83.
41. Stella MC, Comoglio PM. 1999. HGF: A multifunctional growth factor controlling cell scattering. Int J Biochem Cell Biol 31:1357-1362.
42. Taniyama Y, Morishita R, Aoki M, Hiraoka K, Yamasaki K, Hashiya N, Matsumoto K, Nakamura T, Kaneda Y, Ogihara T. 2002. Angiogenesis and antifibrotic action by hepatocyte growth factor in cardiomyopathy. Hypertension 40:47-53.
43. Tilg H, Diehl AM. 2000. Cytokines in alcoholic and nonalcoholic steatohepatitis. N Engl J Med 343:1467-1476.
44. van't Veer MB, Brooijmans AM, Langerak AW, Verhaaf B, Goudswaard CS, Graveland WJ, van Lom K, Valk PJ. 2006. The predictive value of lipoprotein lipase for survival in chronic lymphocytic leukemia. Haematologica 91:56-63.
45. Vogel S, Piantedosi R, Frank J, Lalazar A, Rockey DC, Friedman SL, Blaner WS. 2000. An immortalized rat liver stellate cell line (HSC-T6): A new cell model for the study of retinoid metabolism in vitro. J Lipid Res 41:882-893.
46. Waisman DM. 2003. Plasminogen: Structure, Activation and Regulation.
47. Wang H, Zhang Y, Heuckeroth RO. 2007. PAI-1 deficiency reduces liver fibrosis after bile duct ligation in mice through activation of tPA. FEBS Lett 581:3098-3104.
48. Wipff PJ, Hinz B. 2008. Integrins and the activation of latent transforming growth factor beta 1-An intimate relationship. Eur J Cell Biol 87:601-615.
49. Yang J, Dai C, Liu Y. 2005. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition. J Am Soc Nephrol 16:68-78.
50. Zheng G, Harris DC. 2004. Plasmin in renal interstitial fibrosis: Innocent or guilty? Kidney Int 66:455-456.